Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients.
Mischinger J, Schöllnast H, Zurl H, Geyer M, Fischereder K, Adelsmayr G, Igrec J, Fritz G, Merdzo-Hörmann M, Elstner J, Schmid J, Triebl A, Trimmel V, Reiter C, Steiner J, Rosenlechner D, Seles M, Pichler GP, Pichler M, Riedl J, Schöpfer-Schwab S, Strobl J, Hutterer GC, Zigeuner R, Pummer K, Augustin H, Ahyai S, Mannweiler S, Fuchsjäger M, Talakic E.
Mischinger J, et al. Among authors: zurl h.
Front Surg. 2022 Oct 6;9:1013389. doi: 10.3389/fsurg.2022.1013389. eCollection 2022.
Front Surg. 2022.
PMID: 36277287
Free PMC article.